Virtual screening of intestinal drug permeability

被引:79
作者
Stenberg, P
Luthman, K
Artursson, P
机构
[1] Uppsala Univ, Uppsala Biomed Ctr, Dept Pharmaceut, SE-75123 Uppsala, Sweden
[2] Univ Tromso, Inst Pharm, Dept Med Chem, N-9037 Tromso, Norway
关键词
intestinal drug absorption; drug transport; polar molecular surface area; hydrogen bonding; lipophilicity;
D O I
10.1016/S0168-3659(99)00239-4
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Lead compounds generated in high throughput drug discovery programmes often have unfavorable biopharmaceutical properties, resulting in a low: success rate of such drug candidates in clinical development. Drug companies and researchers would thus like to have methods of predicting biopharmaceutical properties accurately. The intestinal permeability to a lead compound is one such property which is particularly important. Therefore, access to methods to accurately predict biopharmaceutical properties such as the intestinal permeability of a large series of compounds, is of particular importance. This review deals with new theoretical methods used to predict intestinal drug permeability. There are several possible transport routes across the intestine, but theoretical methods generally deal with only one of them, the passive transcellular route. Therefore, this review will also discuss the relative importance of passive and active drug transport and efflux routes using recent data generated in cell cultures, animal models and human subjects. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:231 / 243
页数:13
相关论文
共 95 条
[1]   SOLUBILITY OF NONELECTROLYTES IN POLAR-SOLVENTS .5. ESTIMATION OF SOLUBILITY OF ALIPHATIC MONOFUNCTIONAL COMPOUNDS IN WATER USING A MOLECULAR SURFACE-AREA APPROACH [J].
AMIDON, GL ;
YALKOWSKY, SH ;
ANIK, ST ;
VALVANI, SC .
JOURNAL OF PHYSICAL CHEMISTRY, 1975, 79 (21) :2239-2246
[2]   P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: The influence of culturing conditions and drug exposure on P-gp expression levels [J].
Anderle, P ;
Niederer, E ;
Rubas, W ;
Hilgendorf, C ;
Spahn-Langguth, H ;
Wunderli-Allenspach, H ;
Merkle, HP ;
Langguth, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (06) :757-762
[3]   PLS regression methods [J].
Höskuldsson, Agnar .
Journal of Chemometrics, 1988, 2 (03) :211-228
[4]   Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond [J].
Artursson, P ;
Borchardt, RT .
PHARMACEUTICAL RESEARCH, 1997, 14 (12) :1655-1658
[5]   CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[6]  
AUDRY E, 1986, EUR J MED CHEM, V21, P71
[7]   Intestinal absorption barriers and transport mechanisms, including secretory transport, for a cyclic peptide, fibrinogen antagonist [J].
Aungst, BJ ;
Saitoh, H .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :114-119
[8]   THE DESIGN OF PEPTIDE ANALOGS FOR IMPROVED ABSORPTION [J].
BARLOW, D ;
SATOH, T .
JOURNAL OF CONTROLLED RELEASE, 1994, 29 (03) :283-291
[9]   Immobilized liposome and biomembrane partitioning chromatography of drugs for prediction of drug transport [J].
Beigi, F ;
Gottschalk, I ;
Hägglund, CL ;
Haneskog, L ;
Brekkan, E ;
Zhang, YX ;
Österberg, T ;
Lundahl, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 164 (1-2) :129-137
[10]   Prediction of intestinal drug absorption properties by three-dimensional solubility parameters [J].
Breitkreutz, J .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1370-1375